These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1179 related items for PubMed ID: 20129363

  • 1. Closure of a coexisting ostium secundum atrial septal defect and patent foramen ovale using a single Amplatzer patent foramen ovale occluder device.
    Luna M, Banerjee S, Brilakis ES.
    Cardiovasc Revasc Med; 2010; 11(1):63-6. PubMed ID: 20129363
    [Abstract] [Full Text] [Related]

  • 2. Defect closure in the lipomatous hypertrophied atrial septum with the Amplatzer muscular ventricular septal defect closure device: a case series.
    Lin CH, Balzer DT, Lasala JM.
    Catheter Cardiovasc Interv; 2011 Jul 01; 78(1):102-7. PubMed ID: 21416575
    [Abstract] [Full Text] [Related]

  • 3. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
    Elmariah S, Furlan AJ, Reisman M, Burke D, Vardi M, Wimmer NJ, Ling S, Chen X, Kent DM, Massaro J, Mauri L, CLOSURE I Investigators.
    JACC Cardiovasc Interv; 2014 Aug 01; 7(8):913-20. PubMed ID: 25147037
    [Abstract] [Full Text] [Related]

  • 4. Residual shunt after percutaneous closure of patent foramen ovale with AMPLATZER occluder devices - influence of anatomic features: a transcranial Doppler and intracardiac echocardiography study.
    Marchese N, Pacilli MA, Inchingolo V, Fanelli R, Loperfido F, Vigna C.
    EuroIntervention; 2013 Jul 01; 9(3):382-8. PubMed ID: 23872652
    [Abstract] [Full Text] [Related]

  • 5. Percutaneous Intervention to Treat Platypnea-Orthodeoxia Syndrome: The Toronto Experience.
    Shah AH, Osten M, Leventhal A, Bach Y, Yoo D, Mansour D, Benson L, Wilson WM, Horlick E.
    JACC Cardiovasc Interv; 2016 Sep 26; 9(18):1928-38. PubMed ID: 27659570
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Transcatheter patent foramen ovale closure is effective in reducing migraine independently from specific interatrial septum anatomy and closure devices design.
    Rigatelli G, Cardaioli P, Dell'Avvocata F, Giordan M, Braggion G, Chinaglia M, Roncon L.
    Cardiovasc Revasc Med; 2010 Sep 26; 11(1):29-33. PubMed ID: 20129358
    [Abstract] [Full Text] [Related]

  • 11. Percutaneous patent foramen ovale closure: outcomes with the Premere and Amplatzer devices.
    Bissessor N, Wong AW, Hourigan LA, Jayasinghe RS, Scalia GS, Burstow DJ, Griffiths LR, Savage M, Walters DL.
    Cardiovasc Revasc Med; 2011 Sep 26; 12(3):164-169. PubMed ID: 21640934
    [Abstract] [Full Text] [Related]

  • 12. Double standards in the world of ASD and PFO management: closure for paradoxical embolism.
    Carroll JD.
    Catheter Cardiovasc Interv; 2009 Dec 01; 74(7):1070-1. PubMed ID: 19950331
    [No Abstract] [Full Text] [Related]

  • 13. Long-term follow-up after PFO device closure: Outcomes and Complications in a Single-center Experience.
    Taggart NW, Reeder GS, Lennon RJ, Slusser JP, Freund MA, Cabalka AK, Cetta F, Hagler DJ.
    Catheter Cardiovasc Interv; 2017 Jan 01; 89(1):124-133. PubMed ID: 27027873
    [Abstract] [Full Text] [Related]

  • 14. Characteristics of adult patients with atrial septal defects presenting with paradoxical embolism.
    Bannan A, Shen R, Silvestry FE, Herrmann HC.
    Catheter Cardiovasc Interv; 2009 Dec 01; 74(7):1066-9. PubMed ID: 19670302
    [Abstract] [Full Text] [Related]

  • 15. Amplatzer occluder versus CardioSEAL/STARFlex occluder: a meta-analysis of the efficacy and safety of transcatheter occlusion for patent foramen ovale and atrial septal defect.
    Li Y, Zhou K, Hua Y, Wang C, Xie L, Fang J, Rong X, Shen J.
    Cardiol Young; 2013 Aug 01; 23(4):582-96. PubMed ID: 23199453
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Influence of hospital volume on outcomes of percutaneous atrial septal defect and patent foramen ovale closure: a 10-years US perspective.
    Singh V, Badheka AO, Patel NJ, Chothani A, Mehta K, Arora S, Patel N, Deshmukh A, Shah N, Savani GT, Rathod A, Manvar S, Thakkar B, Panchal V, Patel J, Palacios IF, Rihal CS, Cohen MG, O'Neill W, De Marchena E.
    Catheter Cardiovasc Interv; 2015 May 01; 85(6):1073-81. PubMed ID: 25534392
    [Abstract] [Full Text] [Related]

  • 18. Stroke due to late device thrombosis following successful percutaneous patent foramen ovale closure.
    Korabathina R, Thaler DE, Kimmelstiel C.
    Catheter Cardiovasc Interv; 2012 Sep 01; 80(3):498-502. PubMed ID: 21953702
    [Abstract] [Full Text] [Related]

  • 19. Medium-term results of transcatheter closure of patent foramen ovale (PFO) with Amplatzer PFO and Cribriform occluders.
    Białkowski J, Wawrzyńczyk M, Karwot B, Fiszer R, Knop M, Szkutnik M.
    Kardiol Pol; 2012 Sep 01; 70(11):1142-6. PubMed ID: 23180522
    [Abstract] [Full Text] [Related]

  • 20. Clinical outcomes of patent foramen ovale closure for paradoxical emboli without echocardiographic guidance.
    Varma C, Benson LN, Warr MR, Yeo E, Yip J, Jaigobin CS, Webb G, McLaughlin PR.
    Catheter Cardiovasc Interv; 2004 Aug 01; 62(4):519-25. PubMed ID: 15274165
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.